Erinn S Gideons

Learn More
Major depressive disorder is a devastating mental disorder. Current antidepressant medications can be effective for some patients with depression; however, these drugs exert mood-elevating effects only after prolonged administration, and a sizable fraction of the patient population fails to respond to treatment. There is an urgent need for faster-acting(More)
Ketamine is an NMDA receptor (NMDAR) antagonist that elicits rapid antidepressant responses in patients with treatment-resistant depression. However, ketamine can also produce psychotomimetic effects that limit its utility as an antidepressant, raising the question of whether the clinically tolerated NMDAR antagonist memantine possesses antidepressant(More)
Lithium is widely used as a treatment for Bipolar Disorder although the molecular mechanisms that underlie its therapeutic effects are under debate. In this study, we show brain-derived neurotrophic factor (BDNF) is required for the antimanic-like effects of lithium but not the antidepressant-like effects in mice. We performed whole cell patch clamp(More)
FEAR CONDITIONING AS A MEASURING TOOL FOR COGNITIVE DEFICITS RELATED TO AMYLOID BURDEN COUPLED WITH IRON, ZINC, AND COPPER IN THE TRANSGENIC TG2576 MOUSE MODEL FOR ALZHEIMER’S DISEASE Andrew J. Burns, M.A. George Mason University, 2008 Thesis Director: Dr. Jane M. Flinn This study utilized the transgenic Tg2576 mouse model of Alzheimer’s Disease (AD) that(More)
  • 1